Clinical trial
Clinical Evaluation Study of Urine hrHPV Detection for the Diagnosis of Presence of Cervical HPV and Correlation of Cervical Lesions
NCT05210348 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation Study of Urine hrHPV Detection for the Diagnosis of Presence of Cervical HPV and Correlation of Cervical Lesions
- Lead sponsor
- Peking University People's Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 15, 2021
- Completion date
- May 1, 2022
- Enrollment
- 1,000 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
adenocarcinoma in situ, atypical glandular cells, atypical glandular cells not otherwise specified, atypical glandular cells, favor neoplastic, atypical squamous cells of undetermined significance, atypical squamous cells, cannot rule out high-grade squamous intraepithelial lesion, cervical adenocarcinoma, cervical cancer, cervical intraepithelial neoplasia grade i, cervical intraepithelial neoplasia grade ii, cervical intraepithelial neoplasia, grade iii, cervical squamous cell carcinoma, cervical squamous intraepithelial lesion, high-grade squamous intraepithelial lesions, human papilloma virus, human papillomavirus infection, low-grade squamous intraepithelial lesion, negative for intraepithelial lesion or malignancy